The Fifth People's Hospital of Suzhou   Report issue

Academic/Hospital Phase 4
Founded: Suzhou China (1959)

Organization Overview

First Clinical Trial
2011
NCT01380951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Liver Cirrhosis (Phase 4)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8